Cargando…
Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review
OBJECTIVE: To report survival outcomes in patients with locally recurrent gynecologic cancers managed with curative-intent radical extirpation, perioperative external beam radiotherapy, and intraoperative radiotherapy (IORT). PATIENTS AND METHODS: We conducted a retrospective cohort analysis of 44 p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606340/ https://www.ncbi.nlm.nih.gov/pubmed/34841199 http://dx.doi.org/10.1016/j.mayocpiqo.2021.10.004 |
_version_ | 1784602324006600704 |
---|---|
author | Delara, Ritchie Yang, Jie Suárez-Salvador, Elena Vora, Sujay Magriña, Javier Butler, Kristina Magtibay, Paul |
author_facet | Delara, Ritchie Yang, Jie Suárez-Salvador, Elena Vora, Sujay Magriña, Javier Butler, Kristina Magtibay, Paul |
author_sort | Delara, Ritchie |
collection | PubMed |
description | OBJECTIVE: To report survival outcomes in patients with locally recurrent gynecologic cancers managed with curative-intent radical extirpation, perioperative external beam radiotherapy, and intraoperative radiotherapy (IORT). PATIENTS AND METHODS: We conducted a retrospective cohort analysis of 44 patients with locally recurrent gynecologic cancer treated at a single tertiary-care center (Mayo Clinic in Arizona) over a 15-year period (January 1, 2004, to July 31, 2019). This cohort included patients with uterine (n=21, 47.7%), ovarian (n=3, 6.8%), cervical (n=11, 25.0%), vaginal (n=2, 4.5%), vulvar (n=1, 2.3%), and unknown primary (n=6, 13.6%) cancer. Curative-intent radical extirpation included pelvic exenteration (n=13, 29.5%), laterally extended endopelvic resection (n=22, 50.0%), excision of para-aortic lymph node metastasis (n=8, 18.2%), and radical vaginectomy (n=1, 2.3%). Of the 44 patients in our cohort, 37 (84.1%) received IORT and 7 (15.9%) had intended to receive IORT but did not receive it. RESULTS: The median follow-up for the 44 patients was 12 months (range, 1 to 161 months). For patients who received IORT, the median progression-free survival (PFS) and overall survival (OS) were 13 and 21 months, respectively, and the 3-year cumulative incidence of central, locoregional, and distant recurrence was 27.0% (10 of 37), 40.5% (15 of 37), and 37.8% (14 of 37), respectively. Surgical margins were classified as negative (28 of 44, 63.6%), microscopic (11 of 44, 25.0%), or macroscopic (5 of 44, 11.4%). Negative, microscopic, and macroscopic surgical margins resulted in 3-year PFS of 51.8%, 20.5%, and 0%, respectively (P=.01) and 3-year OS of 62.9%, 20.0%, and 0%, respectively (P=.035). Progression-free survival (P=.69) and OS (P=.88) were not different between patients with negative surgical margins who received (n=21) and did not receive (n=7) IORT. Ten of 37 patients (27.0%) had development of grade 3 or higher toxicities, with 1 death due to sepsis. CONCLUSION: Complete tumor resection at the time of curative-intent radical extirpation achieved higher rates of PFS and OS regardless of IORT administration. |
format | Online Article Text |
id | pubmed-8606340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86063402021-11-26 Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review Delara, Ritchie Yang, Jie Suárez-Salvador, Elena Vora, Sujay Magriña, Javier Butler, Kristina Magtibay, Paul Mayo Clin Proc Innov Qual Outcomes Original Article OBJECTIVE: To report survival outcomes in patients with locally recurrent gynecologic cancers managed with curative-intent radical extirpation, perioperative external beam radiotherapy, and intraoperative radiotherapy (IORT). PATIENTS AND METHODS: We conducted a retrospective cohort analysis of 44 patients with locally recurrent gynecologic cancer treated at a single tertiary-care center (Mayo Clinic in Arizona) over a 15-year period (January 1, 2004, to July 31, 2019). This cohort included patients with uterine (n=21, 47.7%), ovarian (n=3, 6.8%), cervical (n=11, 25.0%), vaginal (n=2, 4.5%), vulvar (n=1, 2.3%), and unknown primary (n=6, 13.6%) cancer. Curative-intent radical extirpation included pelvic exenteration (n=13, 29.5%), laterally extended endopelvic resection (n=22, 50.0%), excision of para-aortic lymph node metastasis (n=8, 18.2%), and radical vaginectomy (n=1, 2.3%). Of the 44 patients in our cohort, 37 (84.1%) received IORT and 7 (15.9%) had intended to receive IORT but did not receive it. RESULTS: The median follow-up for the 44 patients was 12 months (range, 1 to 161 months). For patients who received IORT, the median progression-free survival (PFS) and overall survival (OS) were 13 and 21 months, respectively, and the 3-year cumulative incidence of central, locoregional, and distant recurrence was 27.0% (10 of 37), 40.5% (15 of 37), and 37.8% (14 of 37), respectively. Surgical margins were classified as negative (28 of 44, 63.6%), microscopic (11 of 44, 25.0%), or macroscopic (5 of 44, 11.4%). Negative, microscopic, and macroscopic surgical margins resulted in 3-year PFS of 51.8%, 20.5%, and 0%, respectively (P=.01) and 3-year OS of 62.9%, 20.0%, and 0%, respectively (P=.035). Progression-free survival (P=.69) and OS (P=.88) were not different between patients with negative surgical margins who received (n=21) and did not receive (n=7) IORT. Ten of 37 patients (27.0%) had development of grade 3 or higher toxicities, with 1 death due to sepsis. CONCLUSION: Complete tumor resection at the time of curative-intent radical extirpation achieved higher rates of PFS and OS regardless of IORT administration. Elsevier 2021-11-19 /pmc/articles/PMC8606340/ /pubmed/34841199 http://dx.doi.org/10.1016/j.mayocpiqo.2021.10.004 Text en © 2021 THE AUTHORS https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Delara, Ritchie Yang, Jie Suárez-Salvador, Elena Vora, Sujay Magriña, Javier Butler, Kristina Magtibay, Paul Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title | Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title_full | Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title_fullStr | Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title_full_unstemmed | Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title_short | Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review |
title_sort | radical extirpation with intraoperative radiotherapy for locally recurrent gynecologic cancer: an institutional review |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606340/ https://www.ncbi.nlm.nih.gov/pubmed/34841199 http://dx.doi.org/10.1016/j.mayocpiqo.2021.10.004 |
work_keys_str_mv | AT delararitchie radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT yangjie radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT suarezsalvadorelena radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT vorasujay radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT magrinajavier radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT butlerkristina radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview AT magtibaypaul radicalextirpationwithintraoperativeradiotherapyforlocallyrecurrentgynecologiccanceraninstitutionalreview |